Geoffrey K. Kilili

FDA investigator

Appears on 7 documents from 2021 to 2025, most often at sites in Ohio. Most often cites responsibilities of quality control unit (21 CFR 211.22).

7
Documents on file
4.3
Observations per 483
2021
First seen
2025
Most recent

What they cite most

From 26 observations

Activity by year

2021: 1, 2024: 4, 2025: 2

Where

Ohio 2 · Brazil 1 · Kentucky 1 · Missouri 1 · New Jersey 1 · New York 1

Is Geoffrey K. Kilili coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Grant Industries Inc.Jun 16, 2025 · Elmwood Park, New Jersey
483 Adare Pharmaceuticals, Inc.Feb 25, 2025 · Vandalia, Ohio
483 INDUCTION THERAPIES LLCOct 18, 2024 · Louisville, Kentucky
483 Solventum US LLCSep 6, 2024 · Columbia, Missouri
483 Rio Biofarma Brasil LtdaMay 9, 2024 · Hortolandia, Brazil
483 ISP Chemicals LLCJan 29, 2024 · Columbus, Ohio
EIR Axsome Therapeutics, Inc.Jul 15, 2021 · New York, New York

About this profile

What does Geoffrey K. Kilili inspect?

Geoffrey K. Kilili appears on 7 documents on file covering 7 sites, most often in Ohio.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.166 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Geoffrey K. Kilili is dated Jun 16, 2025.